IC 16-18-2-199 — "Legend drug"

Bills citing this section

• SB 802026Signed into law

  Code publication.

Section text

Sec. 199. "Legend drug", for purposes of IC 16-42, means a drug that is: (1) subject to 21 U.S.C. 353(b)(1); or (2) listed in the Prescription Drug Product List as: (A) published in United States Department of Health and Human Services Approved Drug Products with Therapeutic Equivalence Evaluations, Tenth Edition, (1990); and (B) revised in United States Department of Health and Human Services, Approved Drug Products with Therapeutic Equivalence Evaluations, Cumulative Supplement to the Tenth Edition, Number 10 (1990).

As added by P.L.2-1993, SEC.1. Amended by P.L.131-2014, SEC.6; P.L.10-2020, SEC.1; P.L.9-2024, SEC.370.

Source: official publisher (2026 edition)

Sections citing IC 16-18-2-199

• IC 24-5-26.5-4
• IC 25-1-9-4
• IC 25-24-3-6
• IC 25-26-13-2
• IC 25-26-14-7
• IC 27-1-24.7-5
• IC 31-9-2.1-151
• IC 34-30-14-2
• IC 35-48-1.1-35
• IC 6-2.5-5-18
• IC 6-2.5-5-19
• IC 6-2.5-5-19.5
• IC 9-13-2-49.1

Sections IC 16-18-2-199 cites

• IC 16-42